Sharanagouda S. Patil

Emergence of Mucormycosis during COVID-19 Pandemic in India

Bramhadev Pattnaik, Sharanagouda S. Patil, Gayatri Vaidya, Mahendra P. Yadav, Shashanka K. Prasad, Chandan Dharmashekar, Bhargav Shreevatsa, Chandrashekar Srinivasa, Kollur Shiva Prasad, P. Ashwini & Chandan Shivamallu · Journal of Pharmaceutical Research International · 2021

The present review describes about the disease and the fungal agent in brief, and also stresses for establishment of mechanically ventilated hospital wards across the country. Second wave of COVID-19 pandemic in India has been complicated by high infection rate (R0), 600% jump in...

Open access Research Article 10.9734/jpri/2021/v33i50B33432

Sensitivity of Propionibacterium acnes towards Commercial Anti-Acne Formulations

Chandan Shivamallu, Safa Sharif, Gayatri Vidya, Chandan Dharmashekar, Bhargav Shreevatsa, Kollur Shiva Prasad, Bramhadev Pattnaik, Sharanagouda S. Patil, Chandrashekar Srinivas, S. M. Gopinath & P. Ashwini · Journal of Pharmaceutical Research International · 2021

Propionibacterium acnes are aerotolerant anaerobic, gram-positive bacilli that form part of normal flora. They produce several pro-inflammatory substances that can trigger an immune response in the host by an influx of inflammatory leukocytes into the strands, causing inflammator...

Open access Research Article 10.9734/jpri/2021/v33i55A33836

Comparative Study of Drug Likeness and Pharmacokinetic Properties of Synthetic Antiviral Drugs to that of Remdesivir: In-silico Approach

Akshatha C, Gayatri Vaidya, Chandan Dharmashekara, Bhargav Shreevatsa, H. S. Vikas, H. H. Bhavana, Kollur Shiva Prasad, Chandrashekar Srinivasa, Sharanagouda S. Patil, S. Bindya, P. Ashwini, Pallavi M, Chandan Shivamallu & Raghu Ram Achar · Journal of Pharmaceutical Research International · 2021

COVID-19's recent appearance in Wuhan, China, has affected more than three million twenty-five million individuals worldwide. It is considered a pandemic disease by WHO. Till now, there is no approved therapeutic for treating COVID-19 infection. The involvement of RNA-dependent R...

Open access Research Article 10.9734/jpri/2021/v33i60B34690

Comprehensive Analysis and Assessment on Codon Usage Pattern of Hemolytic Genes from Different Strains of Leptospira interrogans

Chandan Dharmashekara, Sabhyata M. Gopal, Gayatri Vaidya, Bhargav Shreevatsa, H. H. Bhavana, Chandrashekar Srinivasa, S. M. Gopinath, Shiva Prasad Kollur, Sharanagouda S. Patil, Kuralayanapalya Puttahonnappa Suresh, Raghu Ram Achar, Ashwini Prasad & Chandan Shivamallu · Journal of Pharmaceutical Research International · 2021

Background: Leptospirosis is a disease that is zoonotic in nature. It is easily able to survive in the environment and gets transmitted from the reservoir hosts such as rat to humans. Though the cause of Leptospira interrogans virulency is not determined, these studies expresses...

Open access Research Article 10.9734/jpri/2021/v33i60B34635

Effect of Anticoagulants on the Survival Rate in Critically Ill COVID-19 Patients

H. M. Akshay, Gayatri Vaidya, Sarika M. Sheety, Chandan Dharmashekara, Bhargav Shreevatsa, Siddesh V. Siddalingegowda, Poojitha B. Sridhara Setty, Chandrashekar Srinivasa, Poojitha B. Sridhara Settee, Sharanagouda S. Patil, S. Bindya, Shiva Prasad Kollur, P. Ashwini & Chandan Shivamallu · Journal of Pharmaceutical Research International · 2021

Background: The World Health Organization (WHO) declared Coronavirus disease 2019 (COVID-19), as a pandemic in January 2020. The morbidity and mortality associated with the disease are enormous COVID-19, with a multi-systemic pathology, exhibits thrombosis as a common manifestati...

Open access Research Article 10.9734/jpri/2021/v33i52A33550